Lessons from Vaccine Development and Future Possibilities
Sponsored
The panel discusses the rapid development of mRNA vaccines, the opportunities for mRNA technology to revolutionize drug discovery and gene therapy, and the need for regulatory collaboration to enable efficient review and access to these innovative treatments.
The rapid progress in mRNA technology has the potential to revolutionize drug development, with speakers emphasizing the need for collaboration, innovation, and regulatory flexibility to accelerate its adoption. They highlighted the technology's versatility and speed, as well as its potential to create a new therapeutic paradigm. Educating other countries about this technology and facilitating global distribution, particularly in the rare disease space, were also discussed.
Discussion Topics
- 0:00 - Success of mRNA vaccines and opportunities to leverage this for other mRNA-based therapies
- 0:29 - Promoting collaboration and innovation in drug development using mRNA technology
- 0:41 - Extracting best practices from mRNA vaccine development to accelerate other mRNA therapies
- 1:41 - Encouraging risk-based regulatory approaches to facilitate timely access to mRNA therapies
- 3:52 - Using mRNA for rapid target evaluation and validation in early drug development
- 5:03 - Advances in mRNA technology for site-specific genomic insertion and gene therapy
- 7:55 - Regulatory reliance and collaboration across countries to enable efficient review of rare disease mRNA treatments
